For pregnant women, how do lipid-based nutrient supplements (LNSs) versus multiple micronutrients (MMNs) affect maternal and infant outcomes?

2020 ◽  
Author(s):  
Ashraf Nabhan ◽  
Passant Eid
Keyword(s):  
Pregnant Women ◽  
Infant Outcomes ◽  
Nutrient Supplements ◽  
Maternal And Infant Outcomes

scholarly journals Identifying fear of childbirth in a UK population: qualitative examination of the clarity and acceptability of existing measurement tools in a small UK sample

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
P. Slade ◽  
K. Balling ◽  
K. Sheen ◽  
G. Houghton
Keyword(s):  
Pregnant Women ◽  
Content Validity ◽  
Cognitive Interview ◽  
Fear Of Childbirth ◽  
Infant Outcomes ◽  
General Anxiety ◽  
Measurement Tools ◽  
The Uk ◽  
Specific Fear ◽  
Maternal And Infant Outcomes

Abstract Background Fear of childbirth is related to but not synonymous with general anxiety, and represents a superior predictor for maternal and infant outcomes. There is a need to improve the identification and provision of support for women experiencing high fear of childbirth. However it is uncertain as to whether existing measurement tools have appropriate content validity (i.e. cover the relevant domains within the construct), practical utility, and whether they are acceptable for use with a UK population. This study aimed to (1) identify the utility and acceptability of existing measures of fear of childbirth (FOC) with a small UK sample and (2) map the content of existing measures to the key concepts of fear of childbirth established by previous research. Methods Ten pregnant women; five with high and five with low fear of childbirth participated in a cognitive interview covering four most commonly used measures of fear of childbirth: 1. The Wijma Delivery Expectancy Questionnaire (WDEQ A), 2. The Oxford Worries about Labour Scale (OWLS), 3. The Slade-Pais Expectations of Childbirth Scale – fear subscale (SPECS) and 4. The Fear of Birth scale (FOBS). Each measure was also reviewed by participants for ease and clarity of understanding and acceptability. The measures were then reviewed against the key domains identified in the fear of childbirth literature to ascertain the adequacy of content validity of each measure. Interviews were analysed using thematic analysis for each scale item. Results All measures except the FOBS, included items that either women did not understand or, if where there was understanding the meanings were inconsistent across women. All measures demonstrated limited acceptability and content validity for the specific construct of FOC. Therefore, none of the measurement tools currently used within the UK met criteria for understanding, acceptability and content validity for measurement of FOC. Conclusions Findings emphasise a need to develop a specific fear of childbirth tool with good clarity which demonstrates appropriate content validity, and that is acceptable in presentation and length for pregnant women in a UK population.

Maternal and Infant Outcomes With Concurrent Treatment of Tuberculosis and HIV Infection in Pregnant Women

2011 ◽  
Vol 56 (2) ◽  
pp. e63-e66 ◽  
Author(s):  
Patricia L Toro ◽  
Karen L Schneider ◽  
Rosalind J Carter ◽  
Elaine J Abrams ◽  
Wafaa M El-Sadr ◽  
...  
Keyword(s):  
Hiv Infection ◽  
Pregnant Women ◽  
Concurrent Treatment ◽  
Infant Outcomes ◽  
Maternal And Infant Outcomes

scholarly journals Maternal and Infant Outcomes during the COVID-19 Pandemic: A Retrospective Study in Guangzhou, China

2021 ◽  
Author(s):  
Jingyun Wang ◽  
Yun Wang ◽  
Mei-yao He ◽  
Yi-xiao Li ◽  
Xin Cheng ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Adverse Outcomes ◽  
Third Trimester ◽  
Peak Period ◽  
Maternal Characteristics ◽  
Infant Outcomes ◽  
Hydroxyvitamin D ◽  
The Third ◽  
Rest Time ◽  
Maternal And Infant Outcomes

Abstract In late December 2019, the COVID-19 pandemic caused a great threat to people’s lives worldwide. As a special category of the population, pregnant women are vulnerable during emergencies. This study was designed to explore whether or not the COVID-19 pandemic has influenced maternal and infant outcomes. We collected maternal characteristics, laboratory results, condition in the third trimester, maternal outcome, fetal or neonatal outcomes, and characteristics of amniotic fluid, umbilical cord and placenta from pregnant women and fetals or newborns in the first affiliated hospital of Jinan university from 24 January to 31 March 2020 (peak period), chose the same types of data at the hospital during the same period in 2019 and 1 January − 23 January 2020 (prior to the outbreak of COVID-19 in 2020) as a control. Our study focused on uncomplicated singleton pregnancies among women not infected by COVID-19. The results demonstrated that there was not an increase in adverse outcomes of pregnant women and newborns during the COVID-19 pandemic; This might be associated with the updated design of major epidemic prevention and control systems in Guangzhou, and the extension of pregnant women’s rest time during the third trimester of pregnancy. Nevertheless, the survey showed an increased incidence rate of 25-hydroxyvitamin D and zinc deficiency in newborns during the epidemic, implying that pregnant women should participate in appropriate physical exercise, increase their exposure to outdoor sunlight and improve nutrition intake to ensure healthy newborns during the quarantine period. Our study has provided some guidance for maternal management during the COVID-19 pandemic.

scholarly journals Antenatal Corticosteroids for Pregnant Women at High Risk of Preterm Delivery with COVID-19 Infection: A Decision Analysis

2020 ◽  
Vol 37 (10) ◽  
pp. 1015-1021 ◽  
Author(s):  
Claire H. Packer ◽  
Clarice G. Zhou ◽  
Alyssa R. Hersh ◽  
Allison J. Allen ◽  
Amy C. Hermesch ◽  
...  
Keyword(s):  
High Risk ◽  
Pregnant Women ◽  
The United States ◽  
Hospitalized Patients ◽  
Antenatal Corticosteroids ◽  
Maternal Deaths ◽  
Corticosteroid Administration ◽  
Infant Outcomes ◽  
Life Years ◽  
Maternal And Infant Outcomes

Objective Antenatal corticosteroids given prior to preterm deliveries reduce the risk of adverse neonatal outcomes. However, steroid administration in the setting of a viral respiratory infection can worsen maternal outcomes. Therefore, the decision to administer corticosteroids must balance the neonatal benefits with the potential harm to the mother if she is infected with the novel coronavirus disease 2019 (COVID-19). This study aimed to determine the gestational ages for which administering antenatal corticosteroids to women at high risk of preterm labor with concurrent COVID-19 infection results in improved combined maternal and infant outcomes. Study Design A decision-analytic model using TreeAge (2020) software was constructed for a theoretical cohort of hospitalized women with COVID-19 in the United States. All model inputs were derived from the literature. Outcomes included maternal intensive care unit (ICU) admission and death, along with infant outcomes of death, respiratory distress syndrome, intraventricular hemorrhage, and neurodevelopmental delay. Quality-adjusted life years (QALYs) were assessed from the maternal and infant perspectives. Sensitivity analyses were performed to determine if the results were robust over a range of assumptions. Results In our theoretical cohort of 10,000 women delivering between 24 and 33 weeks of gestation with COVID-19, corticosteroid administration resulted in 2,200 women admitted to the ICU and 110 maternal deaths. No antenatal corticosteroid use resulted in 1,500 ICU admissions and 75 maternal deaths. Overall, we found that corticosteroid administration resulted in higher combined QALYs up to 31 weeks of gestation in all hospitalized patients, and up to 29 weeks of gestation in ICU patients. Conclusion Administration of antenatal corticosteroids at less than 32 weeks of gestation for hospitalized patients and less than 30 weeks of gestation for patients admitted to the ICU resulted in higher combined maternal and infant outcomes compared with expectant management for women at high risk of preterm birth with COVID-19 infection. These results can guide clinicians in their counseling and management of these pregnant women. Key Points

Sign in / Sign up

Export Citation Format

Share Document